Matteo S. Carlino, MD, PhD, FRACP, discussed V940 plus pembrolizumab data, safety, and administration in resected melanoma. CancerNetwork® spoke with Matteo S. Carlino, MD, PhD, FRACP, a medical ...
CAMBRIDGE, United Kingdom, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results